BR0308701A - Método de estimulação do crescimento de osso novo em mamìfero - Google Patents

Método de estimulação do crescimento de osso novo em mamìfero

Info

Publication number
BR0308701A
BR0308701A BR0308701-8A BR0308701A BR0308701A BR 0308701 A BR0308701 A BR 0308701A BR 0308701 A BR0308701 A BR 0308701A BR 0308701 A BR0308701 A BR 0308701A
Authority
BR
Brazil
Prior art keywords
new bone
stimulate
bone growth
bone
growth
Prior art date
Application number
BR0308701-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Hector F Deluca
J Wesley Pike
Nirupama K Shevde
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28673538&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0308701(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of BR0308701A publication Critical patent/BR0308701A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
BR0308701-8A 2002-03-25 2003-03-12 Método de estimulação do crescimento de osso novo em mamìfero BR0308701A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/105,826 US20030195175A1 (en) 2002-03-25 2002-03-25 Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
PCT/US2003/007443 WO2003082300A1 (en) 2002-03-25 2003-03-12 Use of carbon-2-modified-vitamin d analogs to induce the formation of new bone

Publications (1)

Publication Number Publication Date
BR0308701A true BR0308701A (pt) 2005-01-18

Family

ID=28673538

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308701-8A BR0308701A (pt) 2002-03-25 2003-03-12 Método de estimulação do crescimento de osso novo em mamìfero

Country Status (20)

Country Link
US (3) US20030195175A1 (https=)
EP (1) EP1494680B1 (https=)
JP (1) JP2005527558A (https=)
KR (1) KR100983953B1 (https=)
CN (1) CN100531739C (https=)
AT (1) ATE406901T1 (https=)
AU (1) AU2003220169B2 (https=)
BR (1) BR0308701A (https=)
CA (1) CA2480125C (https=)
DE (1) DE60323351D1 (https=)
DK (1) DK1494680T3 (https=)
ES (1) ES2312764T3 (https=)
HK (1) HK1079996B (https=)
IL (1) IL164275A0 (https=)
MX (1) MXPA04009288A (https=)
NZ (1) NZ535843A (https=)
PL (1) PL372346A1 (https=)
PT (1) PT1494680E (https=)
WO (1) WO2003082300A1 (https=)
ZA (1) ZA200408153B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100413507C (zh) * 2003-09-19 2008-08-27 威斯康星州男校友研究基金会 治疗骨质稀少或雄性骨质疏松的2-亚烷基-19-去甲-维生素d衍生物
RU2326674C2 (ru) * 2003-09-19 2008-06-20 Пфайзер Продактс Инк. Производные 2-алкилиден-19-нор-витамина d для лечения слабости, поражения мышц или саркопении
BRPI0414448A (pt) * 2003-09-19 2006-11-14 Pfizer Prod Inc composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e um agonista/antagonista de estrogênio
WO2005027928A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. 2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism
WO2005027919A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. 2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture
US7214671B2 (en) * 2004-02-19 2007-05-08 Wisconsin Alumni Research Foundation Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases
KR20070015588A (ko) 2004-05-07 2007-02-05 위스콘신 얼럼나이 리서어치 화운데이션 배아 줄기 세포로부터 중간엽 줄기 세포를 형성하는 방법
WO2006061683A1 (en) * 2004-12-09 2006-06-15 Pfizer Products Inc. 2-alkylidene-19-nor-vitamin d derivatives for the treatment of osteogenesis imperfecta
US7803789B2 (en) * 2006-02-02 2010-09-28 Wisconsin Alumni Research Foundation Vitamin D analog—RAK, methods and uses thereof
US7528122B2 (en) 2006-02-02 2009-05-05 Wisconsin Alumni Research Foundation Vitamin D analog—NEL, methods and uses thereof
WO2010120698A1 (en) * 2009-04-17 2010-10-21 Vidasym, Llc Vitamin d receptor agonists and uses thereof
CA2991260A1 (en) * 2015-08-05 2017-02-09 Wisconsin Alumni Research Foundation Synthesis and biological activity of 2-methylene analogs of calcitriol and related compounds
CN111588506B (zh) * 2020-01-02 2022-01-25 南京医科大学 一种含维生素c的钛种植体存储液的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US584928A (en) * 1897-06-22 Schlag
US4666634A (en) * 1984-12-05 1987-05-19 Chugai Seiyaku Kabushiki Kaisha vitamin D3 derivatives having a substituent at 2-position
IL74617A (en) * 1985-03-15 1988-11-15 Yeda Res & Dev Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals
US5246925A (en) * 1989-03-09 1993-09-21 Wisconsin Alumni Research Foundation 19-nor-vitamin D compounds for use in treating hyperparathyroidism
CA1333616C (en) * 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
US5556645A (en) * 1990-01-12 1996-09-17 Bockman; Richard Methods of enhancing wound healing and tissue repair
US5086191A (en) * 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
EP0619306B1 (en) * 1993-04-05 1996-09-11 Wisconsin Alumni Research Foundation 19-Nor-vitamin D3 compounds with substituent at 2-position
US5565589A (en) * 1993-11-03 1996-10-15 Wisconsin Alumni Research Foundation 17-formyl-5,6-trans-vitamin D compounds
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
JP3372259B2 (ja) * 1995-09-21 2003-01-27 ウィスコンシン・アルムニ・リサーチ・ファウンデーション カルシトリオール誘導体およびそれらの用途
US5976142A (en) * 1996-10-16 1999-11-02 Chin; Martin Apparatus and method for distraction osteogenesis of small alveolar bone
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
US5945410A (en) * 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US6306844B1 (en) * 1997-03-17 2001-10-23 Wisconsin Alumni Research Foundation Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
US6392071B1 (en) * 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
ATE417927T1 (de) * 1997-07-30 2009-01-15 Univ Emory Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme
MXPA03000406A (es) * 2000-07-14 2003-06-06 Wisconsin Alumni Res Found Uso de 2-metilen-19-nor-20(s)-1 alfa,25-dihidroxivitamina d3 para incrementar la resistencia de los huesos.

Also Published As

Publication number Publication date
US20110112056A1 (en) 2011-05-12
WO2003082300A1 (en) 2003-10-09
ATE406901T1 (de) 2008-09-15
HK1079996A1 (zh) 2006-04-21
EP1494680A1 (en) 2005-01-12
JP2005527558A (ja) 2005-09-15
DK1494680T3 (da) 2008-11-17
US20030195175A1 (en) 2003-10-16
ES2312764T3 (es) 2009-03-01
CN1655797A (zh) 2005-08-17
PT1494680E (pt) 2008-10-21
IL164275A0 (en) 2005-12-18
KR100983953B1 (ko) 2010-09-27
AU2003220169A1 (en) 2003-10-13
CA2480125C (en) 2009-12-29
AU2003220169B2 (en) 2008-09-11
PL372346A1 (en) 2005-07-11
ZA200408153B (en) 2006-03-29
HK1079996B (zh) 2010-04-01
NZ535843A (en) 2006-03-31
EP1494680B1 (en) 2008-09-03
CN100531739C (zh) 2009-08-26
MXPA04009288A (es) 2005-06-08
DE60323351D1 (de) 2008-10-16
CA2480125A1 (en) 2003-10-09
US20050203071A1 (en) 2005-09-15
KR20040095346A (ko) 2004-11-12

Similar Documents

Publication Publication Date Title
BR0308701A (pt) Método de estimulação do crescimento de osso novo em mamìfero
Cohen et al. Iliac versus cranial bone for secondary grafting of residual alveolar clefts
Yıldırım et al. Effect of topically applied hyaluronic acid on pain and palatal epithelial wound healing: An examiner‐masked, randomized, controlled clinical trial
Block et al. Use of distraction osteogenesis for maxillary advancement: preliminary results
BR9405843A (pt) Processo para reduzir perda óssea e uso de um composto
NO20022442D0 (no) Legemidler for sykdommer i forbindelse med reduksjon i benmasse
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
Uckan et al. Distraction osteogenesis of basal mandibular bone for reconstruction of the alveolar ridge
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
BR0113184A (pt) Implante artificial e processo para produzir o mesmo
BR0214967A (pt) Composto, sal famaceuticamente aceitável, processo para a preparação de um composto, composição farmacêutica, uso de um composto e método de tratar um distúrbio de um paciente
BR0208427A (pt) Uso do ozÈnio para tratamento de condições dentárias e orais
BR0316877A (pt) Derivados de aril-quinazolina/aril-2-amino-fenil metanona que promovem a liberação de hormÈnio da paratireóide
BR0214364A (pt) Métodos para obter melhorada qualidade dos ossos de um vertebrado e para modular a qualidade dos ossos de um vertebrado, uso de glutamato, derivados de glutamato, ou metabólitos, análogos de glutamato ou misturas dos mesmos, e, método para inibir, prevenir ou aliviar a degradação da estrutura óssoa ou enfraquecimento óssea em um vertebrado
PT1069902E (pt) Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes
BRPI0410654A (pt) composto, composição farmacêutica, uso de um composto, método para tratar um distúrbio de um paciente, e, processo para a preparação de um composto
Posnick et al. Nasal reconstruction with full-thickness cranial bone grafts and rigid internal skeleton fixation through a coronal incision
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
BRPI0407178A (pt) Composição farmacêutica osteogênica
AR010903A1 (es) Preparacion farmaceutica, un procedimiento para prepararla y su empleo en calidad de medicamento.
ATE198418T1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
Barutca et al. Effects of palatine bone denudation repair with periosteal graft on maxillary growth: an experimental study in rats
DK1474185T3 (da) Titaniumimplantat, som erstatter et legemeled, med et eller flere grundlegemer
BRPI0410657A (pt) composto, composição farmacêutica, uso de um composto, método para tratar um distúrbio de um paciente, e, processo para a preparação de um composto
SE0101256D0 (sv) Treatment of low back pain

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.